Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/57451
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vera Golder | en_US |
dc.contributor.author | Rangi Kandane-Rathnayake | en_US |
dc.contributor.author | Alberta Yik Bun Hoi | en_US |
dc.contributor.author | Molla Huq | en_US |
dc.contributor.author | Worawit Louthrenoo | en_US |
dc.contributor.author | Yuan An | en_US |
dc.contributor.author | Zhan Guo Li | en_US |
dc.contributor.author | Shue Fen Luo | en_US |
dc.contributor.author | Sargunan Sockalingam | en_US |
dc.contributor.author | Chak Sing Lau | en_US |
dc.contributor.author | Mo Yin Mok | en_US |
dc.contributor.author | Aisha Lateef | en_US |
dc.contributor.author | Kate Franklyn | en_US |
dc.contributor.author | Susan Morton | en_US |
dc.contributor.author | Sandra Teresa V. Navarra | en_US |
dc.contributor.author | Leonid Zamora | en_US |
dc.contributor.author | Yeong Jian Wu | en_US |
dc.contributor.author | Laniyati Hamijoyo | en_US |
dc.contributor.author | Madelynn Chan | en_US |
dc.contributor.author | Sean O'Neill | en_US |
dc.contributor.author | Fiona Goldblatt | en_US |
dc.contributor.author | Mandana Nikpour | en_US |
dc.contributor.author | Eric Francis Morand | en_US |
dc.date.accessioned | 2018-09-05T03:41:38Z | - |
dc.date.available | 2018-09-05T03:41:38Z | - |
dc.date.issued | 2017-03-20 | en_US |
dc.identifier.issn | 14786362 | en_US |
dc.identifier.issn | 14786354 | en_US |
dc.identifier.other | 2-s2.0-85015641672 | en_US |
dc.identifier.other | 10.1186/s13075-017-1256-6 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85015641672&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/57451 | - |
dc.description.abstract | © 2017 The Author(s). Background: Systemic lupus erythematosus (SLE) is associated with significant impairment of health-related quality of life (HR-QoL). Recently, meeting a definition of a lupus low disease activity state (LLDAS), analogous to low disease activity in rheumatoid arthritis, was preliminarily validated as associated with protection from damage accrual. The LLDAS definition has not been previously evaluated for association with patient-reported outcomes. The objective of this study was to determine whether LLDAS is associated with better HR-QoL, and examine predictors of HR-QoL, in a large multiethnic, multinational cohort of patients with SLE. Methods: HR-QoL was measured using the Medical Outcomes Study 36-item short form health survey (SF-36v2) in a prospective study of 1422 patients. Disease status was measured using the SLE disease activity index (SLEDAI-2 K), physician global assessment (PGA) and LLDAS. Results: Significant differences in SF-36 domain scores were found between patients stratified by ethnic group, education level and damage score, and with the presence of active musculoskeletal or cutaneous manifestations. In multiple linear regression analysis, Asian ethnicity (p < 0.001), a higher level of education (p < 0.001), younger age (p < 0.001) and shorter disease duration (p < 0.01) remained significantly associated with better physical component scores (PCS). Musculoskeletal disease activity (p < 0.001) was negatively associated with PCS, and cutaneous activity (p = 0.04) was negatively associated with mental component scores (MCS). Patients in LLDAS had better PCS (p < 0.001) and MCS (p < 0.001) scores and significantly better scores in multiple individual SF-36 domain scores. Disease damage was associated with worse PCS (p < 0.001), but not MCS scores. Conclusions: Ethnicity, education, disease damage and specific organ involvement impacts HR-QoL in SLE. Attainment of LLDAS is associated with better HR-QoL. | en_US |
dc.subject | Immunology and Microbiology | en_US |
dc.subject | Medicine | en_US |
dc.title | Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Arthritis Research and Therapy | en_US |
article.volume | 19 | en_US |
article.stream.affiliations | Monash University | en_US |
article.stream.affiliations | University of Melbourne | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
article.stream.affiliations | Peking University | en_US |
article.stream.affiliations | Chang Gung Memorial Hospital | en_US |
article.stream.affiliations | University of Malaya | en_US |
article.stream.affiliations | The University of Hong Kong | en_US |
article.stream.affiliations | National University Hospital, Singapore | en_US |
article.stream.affiliations | Monash Health | en_US |
article.stream.affiliations | University of Santo Tomas Hospital | en_US |
article.stream.affiliations | Universitas Padjadjaran | en_US |
article.stream.affiliations | Tan Tock Seng Hospital | en_US |
article.stream.affiliations | University of New South Wales (UNSW) Australia | en_US |
article.stream.affiliations | Royal Adelaide Hospital | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.